UA101168C2 - 4-(тетразол-5-ил)хиназолиновые производные как противораковые средства - Google Patents
4-(тетразол-5-ил)хиназолиновые производные как противораковые средстваInfo
- Publication number
- UA101168C2 UA101168C2 UAA201006435A UAA201006435A UA101168C2 UA 101168 C2 UA101168 C2 UA 101168C2 UA A201006435 A UAA201006435 A UA A201006435A UA A201006435 A UAA201006435 A UA A201006435A UA 101168 C2 UA101168 C2 UA 101168C2
- Authority
- UA
- Ukraine
- Prior art keywords
- quinazoline derivatives
- tetrazol
- novel
- cancer agents
- anti cancer
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Abstract
Это изобретение касается замещенных 4-(тетразол-5-ил)хиназолиновых производных формулы I или их фармацевтически приемлемых солей, которые имеют антипролиферативную активность, такую как противораковая активность, и, соответственно, являются пригодными для лечения человека и животного. Это изобретение также касается способов получения замещенных 4-(тетразол-5-ил)хиназолиновых производных, фармацевтических композиций, которые содержат эти соединения, и их применения для получения лекарственных средств для оказания антипролиферативного воздействия на млекопитающих, включая человека.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN2445CH2007 | 2007-10-29 | ||
PCT/IN2008/000708 WO2009057139A2 (en) | 2007-10-29 | 2008-10-28 | Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents |
Publications (1)
Publication Number | Publication Date |
---|---|
UA101168C2 true UA101168C2 (ru) | 2013-03-11 |
Family
ID=40433677
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201006435A UA101168C2 (ru) | 2007-10-29 | 2008-10-28 | 4-(тетразол-5-ил)хиназолиновые производные как противораковые средства |
Country Status (15)
Country | Link |
---|---|
US (1) | US8080558B2 (ru) |
EP (1) | EP2220054A2 (ru) |
JP (1) | JP2011502141A (ru) |
KR (1) | KR20100087185A (ru) |
CN (1) | CN101878203A (ru) |
AU (1) | AU2008320342B2 (ru) |
CA (1) | CA2703767A1 (ru) |
EA (1) | EA018716B1 (ru) |
GE (1) | GEP20125603B (ru) |
MX (1) | MX2010004625A (ru) |
MY (1) | MY150054A (ru) |
NZ (1) | NZ585357A (ru) |
UA (1) | UA101168C2 (ru) |
WO (1) | WO2009057139A2 (ru) |
ZA (1) | ZA201002807B (ru) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103130729B (zh) * | 2011-12-05 | 2015-07-15 | 齐鲁制药有限公司 | 一种4-氯代-7-甲氧基喹唑啉-6-醇乙酸酯的制备方法 |
EP2892534B8 (en) | 2012-09-06 | 2021-09-15 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
CN102993114B (zh) * | 2012-10-11 | 2015-08-12 | 南通市华峰化工有限责任公司 | 一种1h-四唑-5-乙酸的生产方法 |
CN103204817B (zh) * | 2013-04-16 | 2018-03-27 | 江西师范大学 | 4‑氰基喹唑啉衍生物的制备方法 |
DE102013008118A1 (de) * | 2013-05-11 | 2014-11-13 | Merck Patent Gmbh | Arylchinazoline |
US10231973B2 (en) | 2015-03-20 | 2019-03-19 | Chai Tai Tianqing Pharmaceutical Group Co., Ltd. | Salts of quinazoline derivative and method for preparing the same |
WO2021083347A1 (zh) * | 2019-11-01 | 2021-05-06 | 正大天晴药业集团股份有限公司 | 喹唑啉衍生物或其盐、或其药物组合物的用途 |
CN114437041B (zh) * | 2022-02-25 | 2023-11-10 | 湖北科技学院 | 一类具有抗肿瘤活性的4-四唑基取代-3,4-二氢喹唑啉衍生物及其制备方法和应用 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3800039A (en) * | 1970-10-21 | 1974-03-26 | Mead Johnson & Co | Antithrombogenic process employing substituted 6,7-dialkoxyquinazolines |
JPH078851B2 (ja) | 1985-07-29 | 1995-02-01 | 鐘淵化学工業株式会社 | 3−フエニルチオメチルスチレン誘導体 |
US4971996A (en) | 1987-03-11 | 1990-11-20 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Hydroxystyrene compounds which are useful as tyrosine kinase inhibitors |
AU632992B2 (en) | 1987-12-24 | 1993-01-21 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Pharmaceutical compositions comprising benzylidene- and cinnamylidene-malononitrile derivatives for the inhibition of proliferative processes in mammalian cells, certain such novel compounds and their preparation |
DE3917982A1 (de) | 1989-06-02 | 1990-12-06 | Behringwerke Ag | Verwendung von xylanpolyhydrogensulfaten zur therapie von zellproliferations-bedingten erkrankungen |
EP0584222B1 (en) | 1991-05-10 | 1997-10-08 | Rhone-Poulenc Rorer International (Holdings) Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
NZ243082A (en) | 1991-06-28 | 1995-02-24 | Ici Plc | 4-anilino-quinazoline derivatives; pharmaceutical compositions, preparatory processes, and use thereof |
PT100905A (pt) * | 1991-09-30 | 1994-02-28 | Eisai Co Ltd | Compostos heterociclicos azotados biciclicos contendo aneis de benzeno, ciclo-hexano ou piridina e de pirimidina, piridina ou imidazol substituidos e composicoes farmaceuticas que os contem |
AU661533B2 (en) * | 1992-01-20 | 1995-07-27 | Astrazeneca Ab | Quinazoline derivatives |
GB9323290D0 (en) | 1992-12-10 | 1994-01-05 | Zeneca Ltd | Quinazoline derivatives |
GB9314893D0 (en) * | 1993-07-19 | 1993-09-01 | Zeneca Ltd | Quinazoline derivatives |
GB9510757D0 (en) | 1994-09-19 | 1995-07-19 | Wellcome Found | Therapeuticaly active compounds |
TW321649B (ru) | 1994-11-12 | 1997-12-01 | Zeneca Ltd | |
GB9424233D0 (en) | 1994-11-30 | 1995-01-18 | Zeneca Ltd | Quinazoline derivatives |
CA2216796C (en) | 1995-03-30 | 2003-09-02 | Pfizer Inc. | Quinazoline derivatives |
GB9508537D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
GB9508535D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivative |
GB9508565D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quiazoline derivative |
AU5343096A (en) | 1995-04-27 | 1996-11-18 | Zeneca Limited | Quinazoline derivatives |
GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
US5747498A (en) | 1996-05-28 | 1998-05-05 | Pfizer Inc. | Alkynyl and azido-substituted 4-anilinoquinazolines |
GB9514265D0 (en) | 1995-07-13 | 1995-09-13 | Wellcome Found | Hetrocyclic compounds |
AR004010A1 (es) | 1995-10-11 | 1998-09-30 | Glaxo Group Ltd | Compuestos heterociclicos |
ES2194181T3 (es) | 1996-02-13 | 2003-11-16 | Astrazeneca Ab | Derivados de quinazolina como inhibidores de vegf. |
GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
CA2249446C (en) | 1996-04-12 | 2008-06-17 | Warner-Lambert Company | Irreversible inhibitors of tyrosine kinases |
HRP970371A2 (en) | 1996-07-13 | 1998-08-31 | Kathryn Jane Smith | Heterocyclic compounds |
WO1998002434A1 (en) | 1996-07-13 | 1998-01-22 | Glaxo Group Limited | Fused heterocyclic compounds as protein tyrosine kinase inhibitors |
CN1230185A (zh) | 1996-07-13 | 1999-09-29 | 葛兰素集团有限公司 | 双环芳杂环化合物用作蛋白质酪氨酸激酶的抑制剂 |
GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
RS49779B (sr) | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
GB9800575D0 (en) | 1998-01-12 | 1998-03-11 | Glaxo Group Ltd | Heterocyclic compounds |
JP4870304B2 (ja) | 1999-09-21 | 2012-02-08 | アストラゼネカ アクチボラグ | キナゾリン誘導体およびそれらの医薬品としての使用 |
GB0002040D0 (en) | 2000-01-28 | 2000-03-22 | Zeneca Ltd | Chemical compounds |
UA73993C2 (ru) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хиназолиновые производные для лечения опухолей и фармацевтическая композиция |
DE10042059A1 (de) | 2000-08-26 | 2002-03-07 | Boehringer Ingelheim Pharma | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung |
EP1382603B1 (en) * | 2001-04-26 | 2008-07-23 | Eisai R&D Management Co., Ltd. | Nitrogenous fused-ring compound having pyrazolyl group as substituent and medicinal composition thereof |
GB0126433D0 (en) | 2001-11-03 | 2002-01-02 | Astrazeneca Ab | Compounds |
DE60231230D1 (de) | 2001-11-03 | 2009-04-02 | Astrazeneca Ab | Quinazolin derivate als antitumor-mittel |
TW200406390A (en) * | 2002-01-17 | 2004-05-01 | Neurogen Corp | Substituted quinazolin-4-ylamine analogues |
US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
WO2004046101A2 (en) | 2002-11-20 | 2004-06-03 | Array Biopharma, Inc. | Cyanoguanidines and cyanoamidines as erbb2 and egfr inhibitors |
GB0309009D0 (en) | 2003-04-22 | 2003-05-28 | Astrazeneca Ab | Quinazoline derivatives |
GB0326459D0 (en) | 2003-11-13 | 2003-12-17 | Astrazeneca Ab | Quinazoline derivatives |
MX2008002363A (es) * | 2005-08-17 | 2008-03-18 | Schering Corp | Ligandos novedosos de cinasa basados en quinolina de alta afinidad. |
MX2009000864A (es) * | 2006-07-28 | 2009-02-03 | Novartis Ag | Quinazolinas 2,4-sustituidas como inhibidores de cinasa de lipido. |
-
2008
- 2008-10-28 EP EP08844368A patent/EP2220054A2/en not_active Withdrawn
- 2008-10-28 EA EA201070543A patent/EA018716B1/ru not_active IP Right Cessation
- 2008-10-28 JP JP2010531646A patent/JP2011502141A/ja active Pending
- 2008-10-28 GE GEAP200811821A patent/GEP20125603B/en unknown
- 2008-10-28 MX MX2010004625A patent/MX2010004625A/es unknown
- 2008-10-28 CN CN200880118458XA patent/CN101878203A/zh active Pending
- 2008-10-28 NZ NZ585357A patent/NZ585357A/en not_active IP Right Cessation
- 2008-10-28 UA UAA201006435A patent/UA101168C2/ru unknown
- 2008-10-28 KR KR1020107011577A patent/KR20100087185A/ko not_active Application Discontinuation
- 2008-10-28 AU AU2008320342A patent/AU2008320342B2/en not_active Ceased
- 2008-10-28 MY MYPI2010001916A patent/MY150054A/en unknown
- 2008-10-28 WO PCT/IN2008/000708 patent/WO2009057139A2/en active Application Filing
- 2008-10-28 US US12/740,527 patent/US8080558B2/en not_active Expired - Fee Related
- 2008-10-28 CA CA2703767A patent/CA2703767A1/en not_active Abandoned
-
2010
- 2010-04-21 ZA ZA2010/02807A patent/ZA201002807B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008320342A1 (en) | 2009-05-07 |
CA2703767A1 (en) | 2009-05-07 |
NZ585357A (en) | 2012-02-24 |
AU2008320342A2 (en) | 2010-09-02 |
KR20100087185A (ko) | 2010-08-03 |
EA018716B1 (ru) | 2013-10-30 |
US20100261740A1 (en) | 2010-10-14 |
EA201070543A1 (ru) | 2010-12-30 |
JP2011502141A (ja) | 2011-01-20 |
MY150054A (en) | 2013-11-29 |
EP2220054A2 (en) | 2010-08-25 |
WO2009057139A3 (en) | 2009-09-24 |
AU2008320342B2 (en) | 2012-07-26 |
US8080558B2 (en) | 2011-12-20 |
WO2009057139A2 (en) | 2009-05-07 |
CN101878203A (zh) | 2010-11-03 |
ZA201002807B (en) | 2011-07-27 |
GEP20125603B (en) | 2012-08-10 |
MX2010004625A (es) | 2010-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200736234A (en) | Chemical compounds | |
MX2007008924A (es) | Compuestos quimicos. | |
WO2007113558A8 (en) | Quinazolinone derivatives having b-raf inhibitory activity | |
TN2015000368A1 (en) | Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor | |
MX2009004908A (es) | Compuestos quimicos. | |
MX2010007523A (es) | Nuevos derivados de pirazolo[3,4-d]pirimidina como farmacos anticancer. | |
MY150054A (en) | Novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents | |
WO2006067445A3 (en) | Csf-1r kinase inhibitors | |
MX2008013212A (es) | 4-anilinquinolina-3-carboxamidas como inhibidores de la cinsa csf-1r. | |
WO2007071963A3 (en) | Quinazoline derivatives, process for their preparation and their use as anti-cancer agents | |
TW200634003A (en) | Chemical compounds | |
TW200616974A (en) | Chemical compounds | |
TW200621259A (en) | Chemical compounds | |
TN2012000249A1 (en) | Pyrazine derivatives and their use in the treatment of neurological disorders | |
TN2013000285A1 (en) | Novel heterocyclic derivatives and their use in the treatment of neurological disorders | |
IN2014DN03206A (ru) | ||
TW200621730A (en) | Chemical compounds | |
UA98961C2 (ru) | Производные пиразинона и их применение в лечении легочных заболеваний | |
WO2010111406A3 (en) | Purine derivatives useful as anti - cancer agents | |
MX343706B (es) | Derivados heterocíclicos novedosos. | |
MX2011009847A (es) | Agentes antihelminticos y su uso. | |
MY179527A (en) | Catecholamine derivatives useful for the treatment of parkinson's disease | |
WO2008068507A3 (en) | 2 -phenylamino, 6- (pyrid-3-yl) quinazoline derivatives as raf-protein kinase inhibitors in cancer treatment | |
MX339644B (es) | Sales de xantilio 3,6-disustituidas. | |
MX2011008899A (es) | Nuevas orto-aminoamidas para el tratamiento del cancer. |